Literature DB >> 19307371

In vitro activity of micafungin against planktonic and sessile Candida albicans isolates.

Melissa J Jacobson1, Kathryn E Steckelberg, Kerryl E Piper, James M Steckelberg, Robin Patel.   

Abstract

Planktonic and sessile susceptibilities to micafungin were determined for 30 clinical isolates of Candida albicans obtained from blood or other sterile sites. Planktonic and sessile MIC(90)s for micafungin were 0.125 and 1.0 microg/ml, respectively.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19307371      PMCID： PMC2687220          DOI： 10.1128/AAC.01724-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

Review 1.  Guidelines for the management of intravascular catheter-related infections.

Authors:  L A Mermel; B M Farr; R J Sherertz; I I Raad; N O'Grady; J S Harris; D E Craven
Journal:  Clin Infect Dis       Date:  2001-04-03       Impact factor: 9.079

2.  Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model.

Authors:  Jennifer A Shuford; Mark S Rouse; Kerryl E Piper; James M Steckelberg; Robin Patel
Journal:  J Infect Dis       Date:  2006-07-28       Impact factor: 5.226

3.  In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates.

Authors:  Jennifer A Shuford; Kerryl E Piper; James M Steckelberg; Robin Patel
Journal:  Diagn Microbiol Infect Dis       Date:  2006-12-01       Impact factor: 2.803

4.  In vitro activity of caspofungin against Candida albicans biofilms.

Authors:  Stefano P Bachmann; Kacy VandeWalle; Gordon Ramage; Thomas F Patterson; Brian L Wickes; John R Graybill; José L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

5.  Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors:  J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

6.  Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.

Authors:  D M Kuhn; T George; J Chandra; P K Mukherjee; M A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals.

Authors:  Hyun Woo Choi; Jong Hee Shin; Sook In Jung; Kyung Hwa Park; Duck Cho; Seung Jung Kee; Myung Geun Shin; Soon Pal Suh; Dong Wook Ryang
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

8.  In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.

Authors:  M A Pfaller; L Boyken; R J Hollis; J Kroeger; S A Messer; S Tendolkar; D J Diekema
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948

9.  In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth.

Authors:  Estelle Cateau; Marie-Hélène Rodier; Christine Imbert
Journal:  J Antimicrob Chemother       Date:  2008-04-10       Impact factor: 5.790

10.  Biofilm formation by Candida species on the surface of catheter materials in vitro.

Authors:  S P Hawser; L J Douglas
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441
View more
  11 in total

1.  E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis.

Authors:  Nao-Aki Watanabe; Mamiko Miyazaki; Takaaki Horii; Koji Sagane; Kappei Tsukahara; Katsura Hata
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Breakthrough invasive candidiasis in patients on micafungin.

Authors:  Christopher D Pfeiffer; Guillermo Garcia-Effron; Aimee K Zaas; John R Perfect; David S Perlin; Barbara D Alexander
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

3.  Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms.

Authors:  M Guembe; J Guinea; L J Marcos-Zambrano; A Fernández-Cruz; T Peláez; P Muñoz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

4.  In vitro assessment of the antifungal and paradoxical activity of different echinocandins against Candida tropicalis biofilms.

Authors:  Tsun Sheng N Ku; Stella M Bernardo; Samuel A Lee
Journal:  J Med Microbiol       Date:  2011-06-23       Impact factor: 2.472

5.  Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assay.

Authors:  Jeniel E Nett; Michael T Cain; Kyler Crawford; David R Andes
Journal:  J Clin Microbiol       Date:  2011-01-12       Impact factor: 5.948

Review 6.  Development and regulation of single- and multi-species Candida albicans biofilms.

Authors:  Matthew B Lohse; Megha Gulati; Alexander D Johnson; Clarissa J Nobile
Journal:  Nat Rev Microbiol       Date:  2017-10-03       Impact factor: 60.633

7.  Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.

Authors:  Maria Simitsopoulou; Pavla Peshkova; Efthymia Tasina; Aspasia Katragkou; Daniela Kyrpitzi; Aristea Velegraki; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

8.  In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation.

Authors:  Małgorzata Prażyńska; Tomasz Bogiel; Eugenia Gospodarek-Komkowska
Journal:  Folia Microbiol (Praha)       Date:  2017-10-05       Impact factor: 2.099

9.  Pharmacodynamic and Immunomodulatory Effects of Micafungin on Host Responses against Biofilms of Candida parapsilosis in Comparison to Those of Candida albicans.

Authors:  Maria Simitsopoulou; Katerina Chlichlia; Daniela Kyrpitzi; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

Review 10.  Micafungin: an evidence-based review of its place in therapy.

Authors:  Pola de la Torre; Annette C Reboli
Journal:  Core Evid       Date:  2014-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.